Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
NanoVibronix is a medical devices business based in the US. NanoVibronix shares (NAOV) are listed on the NASDAQ and all prices are listed in US Dollars. NanoVibronix employs 12 staff and has a trailing 12-month revenue of around $1.6 million.
Finder Award
SoFi Invest
Robinhood
tastyworks
| Latest market close | $0.31 |
|---|---|
| 52-week range | $0.22 - $1.36 |
| 50-day moving average | $0.33 |
| 200-day moving average | $0.53 |
| Wall St. target price | $10.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.40 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.314 from 2023-01-27
| 1 week (2023-01-23) | -1.26% |
|---|---|
| 1 month (2022-12-30) | 24.60% |
| 3 months (2022-10-28) | -24.66% |
| 6 months (2022-07-29) | -52.56% |
| 1 year (2022-01-28) | -60.75% |
|---|---|
| 2 years (2021-01-29) | -71.96% |
| 3 years (2020-01-30) | 2.8 |
| 5 years (2018-01-30) | 4.7213 |
| Revenue TTM | $1.6 million |
|---|---|
| Gross profit TTM | $770,000 |
| Return on assets TTM | -48.85% |
| Return on equity TTM | -98.83% |
| Profit margin | 0% |
| Book value | $0.11 |
| Market capitalisation | $10.1 million |
TTM: trailing 12 months
We're not expecting NanoVibronix to pay a dividend over the next 12 months.
NanoVibronix's shares were split on a 1001:1000 basis on 12 October 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1001 shares. This wouldn't directly have changed the overall worth of your NanoVibronix shares – just the quantity. However, indirectly, the new 0.1% lower share price could have impacted the market appetite for NanoVibronix shares which in turn could have impacted NanoVibronix's share price.
Over the last 12 months, NanoVibronix's shares have ranged in value from as little as $0.22 up to $1.3601. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NanoVibronix's is 0.7956. This would suggest that NanoVibronix's shares are less volatile than average (for this exchange).
NanoVibronix, Inc. , through its subsidiary, NanoVibronix Ltd. , focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.